ARCHIMED-backed Instem completed the acquisition of Xybion Digital from Banerjee Group.

ARCHIMED-backed Instem, a company specialising in platforms for preclinical study management, completed the acquisition of Xybion Digital, a software development firm, from Banerjee Group, a private investment and holding company. Financial terms were not disclosed. “The combination of these two companies effectively creates a ‘new Instem’ in the preclinical R&D space – a leader with unparallelled scale and talent enabling us to better focus on our mission to help our customers make discoveries, and to accelerate and advance their research programs. We will also now have more resources to devote to innovation and toward delighting customers. We believe this is a truly transformational development in the field of preclinical life sciences R&D. I also want to take this opportunity to welcome Xybion’s employees to Instem and express how delighted I am that we are joining forces.” Vik Krishnan, Instem CEO.